Paclitaxel Kabi 6 mg/ml Solution for Injection 16.7ml Vial

Paclitaxel Kabi 6 mg/ml Solution for Injection is a crucial chemotherapeutic agent designed for the treatment of various types of cancer. As seen on leading pharmaceutical and e-commerce platforms like NahdiOnline, , and , this medication is integral to oncology protocols worldwide.

Each 16.7ml vial contains Paclitaxel at a concentration of 6 mg/ml, providing a potent formulation for intravenous administration. This product is manufactured by Fresenius Kabi, a renowned global healthcare company specializing in medicines and technologies for infusion, transfusion, and clinical nutrition.

Benefits of Use

Paclitaxel Kabi is highly effective in combating the proliferation of various cancer cells. Its key benefits include:

• Effective in the treatment of advanced ovarian cancer.
• Used for breast cancer, both as adjuvant therapy and for metastatic disease.
• Indicated for non-small cell lung cancer (NSCLC).
• Beneficial in Kaposi's sarcoma in patients with advanced HIV infection.
• Works by disrupting microtubule function, essential for cell division, thereby inhibiting cancer cell growth.

How to Use

Paclitaxel Kabi 6 mg/ml Solution for Injection must be administered by a qualified healthcare professional in a clinical setting.

1. The solution is typically diluted before intravenous infusion.
2. Dosage and duration of treatment are determined by the physician based on the patient's specific cancer type, stage, body surface area, and response to therapy.
3. The infusion rate is carefully monitored to minimize potential side effects.
4. Regular blood tests and patient assessments are conducted throughout the treatment course.

Caution & Warnings

• Administration: This product must only be administered under the supervision of a physician experienced in cancer chemotherapeutic agents.
• Hypersensitivity Reactions: Severe hypersensitivity reactions may occur, requiring premedication with corticosteroids, antihistamines, and H2 antagonists.
• Myelosuppression: Bone marrow suppression (neutropenia) is a dose-limiting toxicity. Frequent monitoring of blood counts is essential.
• Peripheral Neuropathy: Development of peripheral neuropathy is common and may require dose adjustment.
• Cardiac Effects: Bradycardia and other cardiac abnormalities have been reported.
• Liver Impairment: Use with caution in patients with hepatic impairment; dose adjustments may be necessary.
• Pregnancy & Lactation: Paclitaxel is teratogenic and embryotoxic. It is contraindicated during pregnancy and breastfeeding. Effective contraception must be used by both male and female patients during and after treatment.
• Drug Interactions: Caution advised with concomitant use of CYP2C8 and CYP3A4 inhibitors or inducers.

Ingredients

• Active Ingredient: Paclitaxel 6 mg/ml.
• Excipients: Polyoxyethylated castor oil (Cremophor EL or Kolliphor EL), Dehydrated alcohol.

Product Details

• Product Name: Paclitaxel Kabi 6 mg/ml Solution for injection.
• Volume: 16.7ml per vial.
• Strength: 6 mg/ml.
• Dosage Form: Solution for injection.
• Packaging: Vial.
• Manufacturer: Fresenius Kabi.
• IBC: 603257004.